11 β-HSD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of 11 β-HSD monoclonal antibodies for research in the field of steroid metabolism. 11 β-HSD monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 11 β-HSD enzymes are central to the interconversion of active and inactive forms of glucocorticoids, influencing numerous physiological processes such as metabolism, immune response, and stress regulation. Dysregulation of 11 β-HSD has been implicated in various diseases, including obesity, diabetes, and hypertension. Understanding the role of 11 β-HSD in these conditions is crucial for developing effective therapeutic strategies. Researchers can explore the molecular mechanisms of glucocorticoid signaling pathways using 11 β-HSD monoclonal antibodies. Current studies focus on how 11 β-HSD influences metabolic disorders and cardiovascular health. Investigating 11 β-HSD function has revealed new potential therapeutic targets for treating metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies for 11 β-HSD research continue to advance scientific understanding of steroid metabolism and its impact on human health.